Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology 

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID-19 Impact on Structural Heart Imaging Market 

5.1. COVID-19 Landscape: Structural Heart Imaging Industry Impact

5.2. COVID-19 Impact Assessment for the Industry

5.3. COVID-19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Structural Heart Imaging Market, By Modality

8.1. Structural Heart Imaging Market, by Modality, 2024-2034

8.1.1. Echocardiogram

8.1.1.1. Market Revenue and Forecast (2024-2032)

8.1.2. Angiogram

8.1.2.1. Market Revenue and Forecast (2024-2032)

8.1.3. CT

8.1.3.1. Market Revenue and Forecast (2024-2032)

8.1.4. MRI

8.1.4.1. Market Revenue and Forecast (2024-2032)

8.1.5. Nuclear Imaging

8.1.5.1. Market Revenue and Forecast (2024-2032)

8.1.6. Others

8.1.6.1. Market Revenue and Forecast (2024-2032)

Chapter 9. Global Structural Heart Imaging Market, By Procedure

9.1. Structural Heart Imaging Market, by Procedure, 2024-2034

9.1.1. Transcatheter Aortic Valve Replacement (TAVR)

9.1.1.1. Market Revenue and Forecast (2024-2032)

9.1.2. Surgical Aortic Valve Replacement (SAVR)

9.1.2.1. Market Revenue and Forecast (2024-2032)

9.1.3. Transcatheter Mitral Valve Repair (TMVR)

9.1.3.1. Market Revenue and Forecast (2024-2032)

9.1.4. Left Atrial Appendage Closure (LAAC)

9.1.4.1. Market Revenue and Forecast (2024-2032)

9.1.5. Annuloplasty

9.1.5.1. Market Revenue and Forecast (2024-2032)

9.1.6. Valvuloplasty

9.1.6.1. Market Revenue and Forecast (2024-2032)

9.1.7. Others

9.1.7.1. Market Revenue and Forecast (2024-2032)

Chapter 10. Global Structural Heart Imaging Market, By Application 

10.1. Structural Heart Imaging Market, by Application, 2024-2034

10.1.1. Valvular Heart Disease

10.1.1.1. Market Revenue and Forecast (2024-2032)

10.1.2. Congenital Heart Disease

10.1.2.1. Market Revenue and Forecast (2024-2032)

Chapter 11. Global Structural Heart Imaging Market, By End-use 

11.1. Structural Heart Imaging Market, by End-use, 2024-2034

11.1.1. Hospitals And Clinics

11.1.1.1. Market Revenue and Forecast (2024-2032)

11.1.2. Ambulatory Surgical Centers

11.1.2.1. Market Revenue and Forecast (2024-2032)

11.1.3. Diagnostic Imaging Centers

11.1.3.1. Market Revenue and Forecast (2024-2032)

11.1.4. Others

11.1.4.1. Market Revenue and Forecast (2024-2032)

Chapter 12. Global Structural Heart Imaging Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Modality (2024-2032)

12.1.2. Market Revenue and Forecast, by Procedure (2024-2032)

12.1.3. Market Revenue and Forecast, by Application (2024-2032)

12.1.4. Market Revenue and Forecast, by End-use (2024-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Modality (2024-2032)

12.1.5.2. Market Revenue and Forecast, by Procedure (2024-2032)

12.1.5.3. Market Revenue and Forecast, by Application (2024-2032)

12.1.5.4. Market Revenue and Forecast, by End-use (2024-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Modality (2024-2032)

12.1.6.2. Market Revenue and Forecast, by Procedure (2024-2032)

12.1.6.3. Market Revenue and Forecast, by Application (2024-2032)

12.1.6.4. Market Revenue and Forecast, by End-use (2024-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Modality (2024-2032)

12.2.2. Market Revenue and Forecast, by Procedure (2024-2032)

12.2.3. Market Revenue and Forecast, by Application (2024-2032)

12.2.4. Market Revenue and Forecast, by End-use (2024-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Modality (2024-2032)

12.2.5.2. Market Revenue and Forecast, by Procedure (2024-2032)

12.2.5.3. Market Revenue and Forecast, by Application (2024-2032)

12.2.5.4. Market Revenue and Forecast, by End-use (2024-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Modality (2024-2032)

12.2.6.2. Market Revenue and Forecast, by Procedure (2024-2032)

12.2.6.3. Market Revenue and Forecast, by Application (2024-2032)

12.2.6.4. Market Revenue and Forecast, by End-use (2024-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Modality (2024-2032)

12.2.7.2. Market Revenue and Forecast, by Procedure (2024-2032)

12.2.7.3. Market Revenue and Forecast, by Application (2024-2032)

12.2.7.4. Market Revenue and Forecast, by End-use (2024-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Modality (2024-2032)

12.2.8.2. Market Revenue and Forecast, by Procedure (2024-2032)

12.2.8.3. Market Revenue and Forecast, by Application (2024-2032)

12.2.8.4. Market Revenue and Forecast, by End-use (2024-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Modality (2024-2032)

12.3.2. Market Revenue and Forecast, by Procedure (2024-2032)

12.3.3. Market Revenue and Forecast, by Application (2024-2032)

12.3.4. Market Revenue and Forecast, by End-use (2024-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Modality (2024-2032)

12.3.5.2. Market Revenue and Forecast, by Procedure (2024-2032)

12.3.5.3. Market Revenue and Forecast, by Application (2024-2032)

12.3.5.4. Market Revenue and Forecast, by End-use (2024-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Modality (2024-2032)

12.3.6.2. Market Revenue and Forecast, by Procedure (2024-2032)

12.3.6.3. Market Revenue and Forecast, by Application (2024-2032)

12.3.6.4. Market Revenue and Forecast, by End-use (2024-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Modality (2024-2032)

12.3.7.2. Market Revenue and Forecast, by Procedure (2024-2032)

12.3.7.3. Market Revenue and Forecast, by Application (2024-2032)

12.3.7.4. Market Revenue and Forecast, by End-use (2024-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Modality (2024-2032)

12.3.8.2. Market Revenue and Forecast, by Procedure (2024-2032)

12.3.8.3. Market Revenue and Forecast, by Application (2024-2032)

12.3.8.4. Market Revenue and Forecast, by End-use (2024-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Modality (2024-2032)

12.4.2. Market Revenue and Forecast, by Procedure (2024-2032)

12.4.3. Market Revenue and Forecast, by Application (2024-2032)

12.4.4. Market Revenue and Forecast, by End-use (2024-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Modality (2024-2032)

12.4.5.2. Market Revenue and Forecast, by Procedure (2024-2032)

12.4.5.3. Market Revenue and Forecast, by Application (2024-2032)

12.4.5.4. Market Revenue and Forecast, by End-use (2024-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Modality (2024-2032)

12.4.6.2. Market Revenue and Forecast, by Procedure (2024-2032)

12.4.6.3. Market Revenue and Forecast, by Application (2024-2032)

12.4.6.4. Market Revenue and Forecast, by End-use (2024-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Modality (2024-2032)

12.4.7.2. Market Revenue and Forecast, by Procedure (2024-2032)

12.4.7.3. Market Revenue and Forecast, by Application (2024-2032)

12.4.7.4. Market Revenue and Forecast, by End-use (2024-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Modality (2024-2032)

12.4.8.2. Market Revenue and Forecast, by Procedure (2024-2032)

12.4.8.3. Market Revenue and Forecast, by Application (2024-2032)

12.4.8.4. Market Revenue and Forecast, by End-use (2024-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Modality (2024-2032)

12.5.2. Market Revenue and Forecast, by Procedure (2024-2032)

12.5.3. Market Revenue and Forecast, by Application (2024-2032)

12.5.4. Market Revenue and Forecast, by End-use (2024-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Modality (2024-2032)

12.5.5.2. Market Revenue and Forecast, by Procedure (2024-2032)

12.5.5.3. Market Revenue and Forecast, by Application (2024-2032)

12.5.5.4. Market Revenue and Forecast, by End-use (2024-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Modality (2024-2032)

12.5.6.2. Market Revenue and Forecast, by Procedure (2024-2032)

12.5.6.3. Market Revenue and Forecast, by Application (2024-2032)

12.5.6.4. Market Revenue and Forecast, by End-use (2024-2032)

Chapter 13. Company Profiles

13.1. GE Healthcare

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Siemens Healthineers AG

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Koninklijke Philips N.V

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Canon Medical System, USA

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Boston Scientific Corporation

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Medtronic

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Edwards Lifesciences Corporation

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Bracco

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. FUJIFILM Holdings Corporations

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Hitachi, Ltd

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms